covid_19_group_logo

The Bergen COVID-19 Research Group (BCRG) is multidisciplinary team of dedicated scientists focusing on basic and clinical COVID-19 research.

As the first group researching COVID-19 in Norway, we have built a unique biobank and published our scientific results in high ranking international peer reviewed journals.

The first case of COVID-19 infection was identified in Bergen on 28th February prior to the declaration of pandemic on 11th March 2020. Rigorous testing of all suspected cases in the community was centralised in Bergen providing a unique opportunity to study the pandemic. Building on our experience from the swine influenza pandemic, our interdisciplinary consortium covering the community, hospitals and Universities aims to understand key clinical, epidemiological, and immunological characteristics of COVID-19 infection in the general population, hospitalised patients and frontline healthcare workers (HCW).

We commenced our study on 6th March collecting baseline pre-exposure and demographics data and serum samples from 1000 HCW. These HCW have been followed up upon suspected or confirmed infection or we have collected exposure history and serum samples 6-8 weeks later. Serological assays have been established in which only infected people have antibodies and allowed us to map exposure. Exposure history and clinical symptoms and blood samples have been collected from all COVID-19 positive community cases up to Easter and their household and close contacts. We will define levels of population-based immunity to SARS-CoV-2 virus in HCW (exposed and/or infected), community and hospitalized patients and the durability of immunity. We will describe the prognostic factors for severe and life-threatening illness in hospitalized patients in Bergen and investigate immunological biomarkers for severe disease. Our immunological and epidemiological findings will provide vital information on the ability of the virus to spread in the Norwegian population and in health care services to inform future policy decisions.

 

Publications

Members of the group

picture-11060-1459588533

Rebecca Jane Cox Brokstad

Professor, PhD. PI and Head of the Influenza Centre

Foto: Svein Lunde, Helse Stavanger

Nina Langeland

Professor, MD, PhD, Medical PI

Kristin

Kristin Greve-Isdahl Mohn

Associate Professor, MD, PhD. Specialist in Infection Medicine

Bjørn

Bjørn Blomberg

Associate Professor, MD, PhD. Specialist in Infection Medicine 

Karl

Karl A. Brokstad

Professor, Dr. Sc. Immunologist and lab. coordinator

UiBlogoMED_gray_m
Logo-Norsk
Haraldsplass
Logo-RGB-bredde-Bergenkommune
logo_Helse_Stavanger_engelsk_positiv_Windows
standard_hvl
FHU
brl-logo-hd_transparent

Sponsors

The-Research-Council-of-Norway
TMS_eng_rgb
social